Latest Period
Q1 2026
Security Snapshot
SELLAS Life Sciences Group, Inc. - Common Stock (SLS) Institutional Ownership
CUSIP: 81642T209
13F Institutional Holders and Ownership History from Q4 2019 to Q1 2026
Institutions Reporting
160
Shares (Excl. Options)
53,961,117
Price
$4.23
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- SLS on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 53,961,117
- Total 13F value
- $228,425,549
- Portfolio coverage rank
- 0%
- Share change
- +16,599,034
- Value change
- +$70,798,422
- Number of holders
- 160
- Shares outstanding
- 178,475,456
- SEC-reported price per share
- $9.18
- Insider filing price
- $9.18
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SLS - SELLAS Life Sciences Group, Inc. - Common Stock is tracked under CUSIP 81642T209.
- 160 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 112 to 160 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $133,935,339 to $228,425,549.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 160 institutions filings for Q1 2026.
Security key
81642T209
Latest holder period
Q1 2026
13F holders
160
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
SLS full holder history
SELLAS Life Sciences Group, Inc. SEC filings
SELLAS Life Sciences Group, Inc. company facts
SELLAS Life Sciences Group, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 81642T209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
SLS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 6.8% | +28% | $51,336,680 | +$27,281,152 | 12,136,331 | +113% | BlackRock, Inc. | 31 Mar 2026 |
| Anson Funds Management LP | 4.9% | -13% | $31,046,889 | +$6,010,196 | 7,481,178 | +24% | Anson Funds Management LP | 31 Dec 2025 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3.7% | $24,560,261 | 6,514,658 | Highbridge Capital Management, LLC | 31 Dec 2025 |
As of 31 Mar 2026, 160 institutional investors reported holding 53,961,117 shares of SELLAS Life Sciences Group, Inc. - Common Stock (SLS). This represents 30% of the company’s total 178,475,456 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
27%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.8% | 12,198,410 | +62% | 0% | $51,599,273 |
| STATE STREET CORP | 4.7% | 8,396,356 | +284% | 0% | $35,516,586 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 7,525,929 | 0% | 0% | $31,834,680 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 3,912,606 | +27% | 0% | $16,554,768 |
| MARSHALL WACE, LLP | 1.1% | 2,037,162 | +52% | 0.01% | $8,617,196 |
| JONES FINANCIAL COMPANIES LLLP | 0.94% | 1,675,077 | +290% | 0% | $7,311,711 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.82% | 1,462,806 | 0% | 0% | $6,187,669 |
| MORGAN STANLEY | 0.75% | 1,336,293 | +50% | 0% | $5,652,520 |
| NORTHERN TRUST CORP | 0.71% | 1,275,984 | +37% | 0% | $5,397,412 |
| VANGUARD FIDUCIARY TRUST CO | 0.67% | 1,202,839 | 0% | 0% | $5,088,009 |
| DAGCO, INC. | 0.58% | 1,028,780 | +78% | 0.94% | $4,351,740 |
| UBS Group AG | 0.42% | 745,419 | +1430% | 0% | $3,153,123 |
| Invesco Ltd. | 0.39% | 698,080 | +1210% | 0% | $2,952,878 |
| Nuveen, LLC | 0.38% | 670,974 | -34% | 0% | $2,838,220 |
| BANK OF AMERICA CORP /DE/ | 0.36% | 641,683 | +536% | 0% | $2,714,320 |
| GOLDMAN SACHS GROUP INC | 0.31% | 555,913 | +35% | 0% | $2,351,512 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.27% | 480,604 | +18% | 0% | $2,032,955 |
| Bank of New York Mellon Corp | 0.27% | 478,366 | +87% | 0% | $2,023,488 |
| TWO SIGMA INVESTMENTS, LP | 0.23% | 403,165 | -63% | 0% | $1,705,388 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.22% | 397,056 | +14% | 0% | $1,679,547 |
| Everhart Financial Group, Inc. | 0.2% | 364,397 | -22% | 0.13% | $1,541,399 |
| Opus Capital Group, LLC | 0.19% | 346,452 | +9.3% | 0.16% | $1,465,000 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.19% | 344,778 | 0% | $1,458,411 | |
| VISION FINANCIAL MARKETS LLC | 0.17% | 304,400 | 1.3% | $1,287,612 | |
| SIMPLEX TRADING, LLC | 0.17% | 295,162 | 0.04% | $1,248,535 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
26
Latest
Q1 2026
Rows shown
1-25 of 26
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 53,961,117 | $228,425,549 | +$70,798,422 | $4.23 | 160 |
| 2025 Q4 | 35,512,660 | $133,935,339 | +$23,683,756 | $3.77 | 112 |
| 2025 Q3 | 32,917,301 | $53,012,951 | +$9,796,863 | $1.61 | 92 |
| 2025 Q2 | 26,771,579 | $58,629,839 | +$27,498,028 | $2.19 | 78 |
| 2025 Q1 | 14,287,843 | $15,431,614 | +$8,743,246 | $1.08 | 43 |
| 2024 Q4 | 6,195,241 | $6,443,955 | +$751,049 | $1.04 | 29 |
| 2024 Q3 | 5,385,570 | $6,729,539 | +$1,661,405 | $1.25 | 30 |
| 2024 Q2 | 4,056,846 | $4,828,846 | -$3,466,325 | $1.19 | 29 |
| 2024 Q1 | 7,717,105 | $7,794,727 | +$4,207,509 | $1.01 | 27 |
| 2023 Q4 | 3,493,044 | $3,702,505 | +$352,826 | $1.06 | 29 |
| 2023 Q3 | 2,751,676 | $4,512,830 | -$594,241 | $1.64 | 25 |
| 2023 Q2 | 3,114,137 | $4,889,035 | +$175,383 | $1.57 | 22 |
| 2023 Q1 | 2,996,127 | $4,284,993 | +$1,438,716 | $1.43 | 20 |
| 2022 Q4 | 1,889,269 | $4,456,259 | +$91,291 | $2.36 | 27 |
| 2022 Q3 | 2,186,943 | $4,418,000 | -$1,738,313 | $2.02 | 25 |
| 2022 Q2 | 2,979,307 | $6,641,000 | +$1,671,317 | $2.23 | 23 |
| 2022 Q1 | 1,688,629 | $11,276,000 | -$279,247 | $6.68 | 25 |
| 2021 Q4 | 1,733,782 | $9,586,000 | -$1,340,161 | $5.53 | 26 |
| 2021 Q3 | 1,859,470 | $17,100,000 | -$844,204 | $9.16 | 29 |
| 2021 Q2 | 1,897,926 | $21,282,000 | +$4,739,163 | $11.10 | 28 |
| 2021 Q1 | 1,552,743 | $13,246,990 | +$5,287,808 | $8.54 | 28 |
| 2020 Q4 | 925,075 | $5,374,000 | +$2,503,596 | $5.81 | 17 |
| 2020 Q3 | 616,674 | $1,633,000 | +$397,179 | $2.65 | 10 |
| 2020 Q2 | 455,904 | $1,335,000 | +$144,563 | $2.93 | 12 |
| 2020 Q1 | 415,637 | $720,000 | -$87,849 | $1.74 | 10 |